natgillin/translations-raw huggingface dataset:
Pharmacotherapeutic group: Bacterial vaccines, ATC-code: J07AE01 Mechanism of action
Farmakoterapeutiline rühm: bakterioloogilised vaktsiinid, ATC-kood: J07AE01 Toimemehhanism
Pharmacotherapeutic group: Bile and liver therapy, bile acid preparations, ATC code: A05AA03 Cholic acid is the predominant primary bile acid in man.
Farmakoterapeutiline grupp: sapi ja maksa ravimid, sapphappe preparaadid, ATC-kood: A05AA03
Pharmacotherapeutic group: Bile and liver therapy, bile acid preparations; ATC code: A05AA03 Mechanism of action
Farmakoterapeutiline rühm: sapiteede ja maksa ravi, sapphappepreparaadid, ATC-kood: A05AA03 Toimemehhanism
Pharmacotherapeutic group: Blood substitutes, ATCvet code: QB05AA90.
Farmakoterapeutiline rühm: vereasendajad, ATCvet kood: QB05AA90
Pharmacotherapeutic group: bluetongue virus vaccine, ATC vet code QI04AA02 (sheep) and QI02AA08 (cattle).
Farmakoterapeutiline rühm: lammaste katarraalse palaviku (Bluetongue) viiruse vaktsiin, ATC vet kood: QI04AA02 (lammastel) ja QI02AA08 (veistel)
Pharmacotherapeutic group: Cardiac therapy, other cardiac preparations, ATC code: C01EB21 Mechanism of action
Farmakoterapeutiline rühm: südameravi, muud südamepreparaadid, ATC-kood: C01EB21 Toimemehhanism
Pharmacotherapeutic group: Chemotherapeutics for topical use, antivirals, ATC Code: D06BB10
Farmakoterapeutiline grupp: kemoterapeutikumid lokaalseks kasutamiseks, viirustevastased ained: ATC-kood: D06BB10.
Pharmacotherapeutic group: Contrast media, paramagnetic contrast media, ATC code: V08CA.
Farmakoterapeutiline grupp: paramagnetiline kontrastaine, ATC-kood: V08CA
Pharmacotherapeutic group: cytostatics (antimetabolites), ATC code: L01BC06
Farmakoterapeutiline grupp: tsütostaatikumid (antimetaboliidid), ATC-kood: L01BC06
Pharmacotherapeutic group: cytostatics (antimetabolites), ATC code: L01BC06
Farmakoterapeutiline rühm: tsütostaatikumid (antimetaboliidid), ATC-kood: L01BC06
Pharmacotherapeutic group: decongestants and antiallergics; other antiallergics, ATC code: S01G X 06
Farmakoterapeutiline rühm: turse- ja allergiavastased ained; teised allergiavastased ained ATC-kood: S01G X 06
Pharmacotherapeutic group: Detoxifying agents for antineoplastic agents, ATC code: V03AF02 Two pharmacodynamic properties of dexrazoxane are described in the literature:
Farmakoterapeutiline grupp: Detoksifitseerivad ained tsütostaatiliseks raviks, ATC-kood: V03AF02 Kirjanduses on kirjeldatud deksrasoksaani kahte farmakodünaamilist omadust:
Pharmacotherapeutic group: diagnostic radiopharmaceutical, central nervous system; ATC code: V09AX06
Farmakoterapeutiline rühm: diagnostiline radiofarmatseutikum, kesknärvisüsteem, ATC-kood: V09AX06
Pharmacotherapeutic group: diagnostic radiopharmaceutical, tumour detection, ATC Code: V09IA09.
Farmakoterapeutiline rühm: diagnostilised radiofarmatseutikumid, kasvajate kindlakstegemine, ATC- kood: V09IA09.
Pharmacotherapeutic group: Digestives, incl. enzymes, Enzyme preparations, ATC code: A09AA02 Mechanism of action
Farmakoterapeutiline rühm: seedimist soodustavad ained, k.a ensüümid, ensüümid, ATC-kood: A09AA02 Toimemehhanism
Pharmacotherapeutic group: Direct acting antiviral, ATC code: not yet assigned
Farmakoterapeutiline rühm: otsese toimega viirusvastased ained, ATC kood: ei ole veel omistatud
Pharmacotherapeutic group: Direct acting antivirals, nucleosides and nucleotides (excl.reverse transcriptase inhibitors), ATC code: J05AB04.
Farmakoterapeutiline rühm: Otsese toimega viirusevastased ained, nukleosiidid ja nukleotiidid (v.a pöördtranskriptaasi inhibiitorid), ATC-kood: J05AB04.
Pharmacotherapeutic group: Direct-acting antiviral, ATC code: J05AX14 Mechanism of action
Farmakoterapeutiline rühm: otsetoimivad viirusevastased ained, ATC-kood: J05AX14 Toimemehhanism
Pharmacotherapeutic group: Direct-acting antiviral, ATC code: J05AX65 Mechanism of action
Farmakoterapeutiline rühm: otsese toimega viirusevastased ained; ATC-kood: J05AX65 Toimemehhanism
Pharmacotherapeutic group: Direct-acting antiviral; ATC code: J05AX15 Mechanism of action
Farmakoterapeutiline rühm: otsese toimega viirusevastased ained; ATC-kood: J05AX15 Toimemehhanism
Pharmacotherapeutic group: Diuretics, vasopressin antagonists, ATC code C03XA01
Farmakoterapeutiline rühm: diureetikumid, vasopressiini antagonistid, ATC-kood: C03XA01
Pharmacotherapeutic group: Drugs affecting bone structure and mineralization, bisphosphonates, ATC code: M05BA08
Farmakoterapeutiline rühm: luustruktuuri ja mineralisatsiooni mõjutavad ravimid, bisfosfonaadid, ATC-kood: M05BA08
Pharmacotherapeutic group: Drugs for acid related disorders Proton pump inhibitors, ATC code: A02BC02
Farmakoterapeutiline rühm: Maomahla happesusega seotud häire raviks kasutatavad ained, prootonpumba inhibiitorid, ATC kood: A02BC02
Pharmacotherapeutic group: Drugs for acid related disorders Proton pump inhibitors, ATC code: A02BC02
Farmakoterapeutiline rühm: Maomahla happesusega seotud häirete raviks kasutatavad ained, prootonpumba inhibiitorid, ATC kood: A02BC02
Pharmacotherapeutic group: Drugs for acid related disorders, proton pump inhibitors, ATC code: A02B C05.
Farmakoterapeutiline rühm: Maomahla happesusega seotud häirete raviks kasutatavad ained, prootonpumba inhibiitorid, ATC-kood: A02BC05
Pharmacotherapeutic group: Drugs for obstructive airway diseases, adrenergics in combination with anticholinergics, ATC code: R03AL03
Farmakoterapeutiline rühm: hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, adrenergilised ained kombinatsioonis antikoliinergiliste ainetega, ATC-kood: R03AL03
Pharmacotherapeutic group: Drugs for obstructive airway diseases, anticholinergics, ATC code: R03BB06
Farmakoterapeutiline rühm: Hingamisteede obstruktiivsete haiguste raviks mõeldud ained, antikolinergilised ained, ATC-kood: R03BB06
Pharmacotherapeutic group: Drugs for obstructive airways diseases, Adrenergics and other drugs for obstructive airway diseases, ATC code: R03AK10.
Farmakoterapeutiline rühm: Hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, adrenergilised ja teised hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, ATC-kood: R03AK10.
Pharmacotherapeutic group: Drugs for the treatment of bone diseases - Other drugs affecting bone structure and mineralisation, ATC code: M05BX03.
Farmakoterapeutiline grupp: Ravimid luuhaiguste raviks – Luustruktuuri ja mineralisatsiooni mõjutavad muud ravimid, ATC-kood: M05BX03
Pharmacotherapeutic group: Drugs for the treatment of bone diseases – other drugs affecting bone structure and mineralisation, ATC code: M05BX04
Farmakoterapeutiline rühm: ravimid luuhaiguste raviks – teised mineralisatsiooni mõjustavad ained; ATC-kood: M05BX04
Pharmacotherapeutic group: Drugs for the treatment of bone diseases – Other drugs affecting bone structure and mineralization, ATC code: M05BX04
Farmakoterapeutiline rühm: luuhaiguste raviks kasutatavad ained – teised luu struktuuri ja mineralisatsiooni mõjutavad ained; ATC-kood: M05BX04
Pharmacotherapeutic group: Drugs for treatment of acetonemia, ATC vet code: QA16QA06
Farmakoterapeutiline rühm: atsetoneemia ravimid, ATCvet kood: QA16QA06
Pharmacotherapeutic group: Drugs for treatment of bone diseases, bisphosphonates ATC code: M05BA08
Farmakoterapeutiline rühm: luuhaiguste raviks kasutatavad ained, bisfosfonaadid, ATC-kood: M05BA08
Pharmacotherapeutic group: Drugs for treatment of bone diseases, bisphosphonates, ATC code: M05 BA 08
Farmakoterapeutiline rühm: luuhaiguste raviks kasutatavad ravimid, bisfosfonaadid, ATC-kood: M05BA08
Pharmacotherapeutic group: Drugs for treatment of bone diseases, bisphosphonates, ATC code: M05BA08 Mechanism of action
Farmakoterapeutiline rühm: luuhaiguste raviks kasutatavad ained, bisfosfonaadid, ATC-kood: M05BA08
Pharmacotherapeutic group: Drugs for treatment of hyperkalemia and hyperphosphatemia ATC code: V03AE08
Farmakoterapeutiline rühm: ained hüperkaleemia ja hüperfosfateemia raviks ATC-kood: V03AE08
Pharmacotherapeutic group: Drugs used in diabetes ,insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, insuliinid ja nende analoogid süstimiseks, keskmise toimeajaga iniminsuliin, mis on kombineeritud kiiresti toimiva insuliiniga, ATC- kood: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes insulins and analogues for injection, fast-acting.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, insuliinid ja nende analoogid, lühikese toimeajaga.
Pharmacotherapeutic group: Drugs used in diabetes insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, insuliinid ja nende analoogid süstimiseks, keskmise toimeajaga iniminsuliin, mis on kombineeritud kiiresti toimiva insuliiniga, ATC- kood: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes, combinations of oral blood glucose lowering drugs, ATC code: A10BD05.
Farmakoterapeutiline rühm: Diabeedi raviks kasutatavad ained, suukaudsete vere glükoosisisaldust vähendavate ainete kombinatsioonid, ATC-kood: A10BD05
Pharmacotherapeutic group: Drugs used in diabetes, Combinations of oral blood glucose lowering drugs, ATC code: A10BD10.
Farmakoterapeutiline grupp: Diabeediravimid.Suukaudsete vere glükoosisisaldust vähendavate ainete kombinatsioonid, ATC-kood: A10BD10.
Pharmacotherapeutic group: Drugs used in diabetes, combinations of oral blood glucose lowering drugs, ATC code: A10BD11
Farmakoterapeutiline rühm: suhkurtõve korral kasutatavad ravimid, vere glükoosisisaldust langetavate suukaudsete ravimite kombinatsioonid; ATC-kood: A10BD11
Pharmacotherapeutic group: Drugs used in diabetes, Dipeptidyl peptidase 4 (DPP-4) inhibitors, ATC code: A10BH01
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, dipeptidüülpeptidaas-4 (DPP-4) inhibiitorid, ATC-kood: A10BH01.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, fast-acting, ATC Code: A10AB01.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, rühm: diabeedi raviks kasutatavad ained, insuliinid ja nende analoogid süstimiseks, lühikese toimeajaga, ATC-kood: A10AB01.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, fast-acting, ATC Code: A10AB01.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained,insuliinid ja nende analoogid süstimiseks, lühikese toimeajaga, ATC-kood: A10AB01.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, insuliinid ja nende analoogid süstimiseks, keskmise toimeajaga iniminsuliin, mis on kombineeritud kiiresti toimiva insuliiniga, ATC- kood: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, insuliinid ja nende analoogid süstimiseks, lühikese toimeajaga ja keskmise toimeajaga iniminsuliinide segu, ATC-kood: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, long-acting.
Farmakoterapeutiline rühm: : diabeedi raviks kasutatavad ained, insuliinid ja analoogid süstimiseks, pika toimeajaga.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, long-acting.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, insuliinid ja analoogid süstimiseks, pika toimeajaga.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, long-acting.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, pika toimeajaga insuliinid ja nende analoogid.
Pharmacotherapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excl. insulins, ATC code: A10BX04.
Farmakoterapeutiline grupp: Diabeedi puhul kasutatavad ravimid, teised veresuhkrut langetavad ravimid, v.a insuliinid, ATC-kood: A10BX04.
Pharmacotherapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excl. insulins, ATC code: A10BX04.
Farmakoterapeutiline grupp: Diabeedi raviks kasutatavad ained, teised vere glükoosisisaldust vähendavad ained, v.a insuliinid, ATC-kood: A10BX04.
Pharmacotherapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excl. insulins, ATC code: A10BX14
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, teised vere glükoosisisaldust vähendavad ained, v.a insuliinid, ATC-kood: A10BX14.
Pharmacotherapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excl. insulins.
Farmakoterapeutiline grupp: Diabeediravimid, teised vere glükoosisisaldust vähendavad ravimid, v.a insuliinid.
Pharmacotherapeutic group: Drugs used in diabetes,insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutiline rühm: diabeedi raviks kasutatavad ained, insuliinid ja nende analoogid süstimiseks, keskmise toimeajaga iniminsuliin, mis on kombineeritud kiiresti toimiva insuliiniga, ATC- kood: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes.
Farmakoterapeutiline rühm,: Diabeedi raviks kasutatavad ained.
Pharmacotherapeutic group: Drugs used in hereditary angioedema, C1 inhibitor, plasma derived, ATC code: B06AC01.
Farmakoterapeutiline rühm: päriliku angioödeemi ravimid, C1 inhibiitor, valmistatud vereplasmast, ATC-kood: B06AC01.
Pharmacotherapeutic group: Ectoparasiticides for systemic use.
Farmakoterapeutiline rühm: Nahaparasiitide vastased ained süsteemseks kasutamiseks.
Pharmacotherapeutic group: Ectoparasiticides for topical use, ATCvet code: QP53AC54
Farmakoterapeutiline rühm: ektoparasiitikumid paikseks kasutamiseks, ATCvet kood: QP53AC54
Pharmacotherapeutic group: Ectoparasiticides for topical use, indoxacarb.
Farmakoterapeutiline rühm: ektoparasiitikumid paikseks kasutamiseks, indoksakarb.
Pharmacotherapeutic group: Emollients and protectives, protectives against UV radiation for systemic use; ATC code: D02BB02
Farmakoterapeutiline rühm: pehmendavad ja kaitsvad ained, UV-kiirguse eest kaitsvad preparaadid süsteemseks kasutamiseks; ATC-kood: D02BB02
Pharmacotherapeutic group: Encephalitis vaccines.
Farmakoterapeutiline rühm: entsefaliidi vaktsiinid.
Pharmacotherapeutic group: Enzymes-Imiglucerase (recombinant macrophage targeted - glucocerebrosidase), ATC code: A16AB02.
Farmakoterapeutiline grupp: ensüümid, imiglütseraas (rekombinantne makrofaagide märklaud - glükotserebrosidaas), ATC kood: A16AB02.
Pharmacotherapeutic group: Gonadotrophin-releasing hormones (GnRH), ATCvet code: QH01CA93.
Farmakoterapeutiline rühm: gonadotropiini vabastavad hormoonid (GnRH), ATCvet kood: QH01CA93.
Pharmacotherapeutic group: Gonadotropin-releasing hormones (GnRH), ATCvet code: QH01CA93.
Farmakoterapeutiline rühm: gonadotropiini vabastavad hormoonid (GnRH), ATCvet kood: QH01CA93.
Pharmacotherapeutic group: Hepatitis vaccines, ATC code: J07BC20.
Farmakoterapeutiline grupp: hepatiidi vaktsiinid, ATC kood: J07BC20.
Pharmacotherapeutic group: Immune sera and immunoglobulins, Specific immunoglobulins, ATC code: J06BB04
Farmakoterapeutiline rühm: immuunseerumid ja immunoglobuliinid, spetsiifilised immunoglobuliinid, ATC–kood: J06BB04
Pharmacotherapeutic group: immune sera and immunoglobulins: immunoglobulins, normal human, for intravascular administration, ATC code: J06BA02.
Farmakoterapeutiline rühm: immuunseerumid ja immuunglobuliinid: inimese normaalimmuunglobuliinid veenisiseseks manustamiseks, ATC-kood: J06BA02
Pharmacotherapeutic group: immune sera and immunoglobulins: immunoglobulins, normal human, for intravascular administration, ATC code: J06BA02.
Farmakoterapeutiline rühm: immuunseerumid ja immuunglobuliinid: inimese normaalimmuunglobuliinid, veenisiseseks manustamiseks, ATC-kood: J06BA02
Pharmacotherapeutic group: immune sera immunoglobulins, specific immunoglobulins; ATC Code: J06BB16.
Farmakoterapeutiline rühm: immuunseerumid ja immunoglobuliinid, spetsiifilised immunoglobuliinid, ATC-kood: J06BB16
Pharmacotherapeutic group: Immunologicals for aves, domestic fowl, live viral vaccine, avian infectious bronchitis virus.
Farmakoterapeutiline rühm : immunoloogilised ained lindudele, kodulinnud, elusviirusvaktsiin, lindude nakkava bronhiidi viirusvaktsiin.
Pharmacotherapeutic group: Immunologicals for Aves, live bacterial vaccines for domestic fowl.
Farmakoterapeutiline rühm: immunoloogilised ained lindudele, elusbaktervaktsiinid kodulindudele.
Pharmacotherapeutic group: Immunologicals for canidae – dog – inactivated parasitic vaccine.
Farmakoterapeutiline rühm: immunoloogilised preparaadid koerlastele – koer – parasiitidevastased inaktiveeritud vaktsiinid.
Pharmacotherapeutic group: Immunologicals for Canidae – dog.
Farmakoterapeutiline rühm: immunoloogilised ained koerlastele – koertele.
Pharmacotherapeutic group: Immunologicals for Canidae, inactivated bacterial vaccine for dogs.
Farmakoterapeutiline rühm: immunoloogilised ained koerlastele, inaktiveeritud baktervaktsiin koertele.
Pharmacotherapeutic group: Immunologicals for Canidae, inactivated bacterial vaccines for dogs.
Farmakoterapeutiline rühm: immunoloogilised ained koerlastele, inaktiveeritud baktervaktsiinid koertele.
Pharmacotherapeutic group: Immunologicals, Inactivated viral vaccines ATC vet code: QI09AA03
Farmakoterapeutiline rühm: Immunoloogilised preparaadid, inaktiveeritud viirusvaktsiinid ATCvet kood: QI09AA03
Pharmacotherapeutic group: Immunologicals, Inactivated viral vaccines ATCvet code: QI09AA03
Farmakoterapeutiline rühm: Immunoloogilised preparaadid, inaktiveeritud viirusvaktsiinid ATCvet kood: QI09AA03
Pharmacotherapeutic group: immunostimulants, colony stimulating factors, ATC code: L03AA02.
Farmakoterapeutiline rühm: immunostimulaatorid, kolooniat stimuleerivad faktorid, ATC-kood: L03AA02
Pharmacotherapeutic group: Immunostimulants, Colony stimulating factors, ATC code: L03AA14
Farmakoterapeutiline rühm: immunostimulaatorid, kolooniat stimuleerivad faktorid, ATC-kood: L03AA14
Pharmacotherapeutic group: Immunostimulants, Interferons, ATC code: L03AB07
Farmakoterapeutiline rühm: immuunsüsteemi stimuleerivad ained, interferoonid, ATC-kood:
Pharmacotherapeutic group: Immunostimulants, Interferons, ATC code: L03AB07
Farmakoterapeutiline rühm: immuunsüsteemi stimuleerivad ained, interferoonid, ATC-kood: L03AB07
Pharmacotherapeutic group: Immunosuppressants, calcineurin inhibitors, ATC code: L04AD02 Mechanism of action
Farmakoterapeutiline rühm: immunosupressandid, kaltsineuriini inhibiitorid, ATC-kood: L04AD02 Toimemehhanism
Pharmacotherapeutic group: immunosuppressants, interleukin inhibitors, ATC code: L04AC01 Mechanism of action
Farmakoterapeutiline rühm: immunosupressandid, interleukiini inhibiitorid, ATC-kood: L04AC01 Toimemehhanism
Pharmacotherapeutic group: Immunosuppressants, Interleukin inhibitors, ATC code: L04AC03
Farmakoterapeutiline rühm: immuunsupressandid, interleukiini inhibiitorid, ATC-kood: L04AC03
Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC05.
Farmakoterapeutiline rühm: immunosupressiivsed ained, interleukiini inhibiitorid, ATC-kood: L04AC05
Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC08 Mechanism of action
Farmakoterapeutiline rühm: Immunosupressandid, interleukiini inhibiitorid, ATC-kood: L04AC08 Toimemehhanism
Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC10 Mechanism of action
Farmakoterapeutiline rühm: Immunosupressandid, interleukiini inhibiitorid, ATC-kood: L04AC10 Toimemehhanism
Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC13 Mechanism of action
Farmakoterapeutiline rühm: Immunosupressandid, interleukiini inhibiitorid, ATC-kood: L04AC13 Toimemehhanism
Pharmacotherapeutic group: Immunosuppressants, Interleukin inhibitors; ATC code: L04AC07.
Farmakoterapeutiline rühm: Immunosupressandid, interleukiini inhibiitorid; ATC-kood: L04AC07.
Pharmacotherapeutic group: Immunosuppressants, other immunosuppressants, ATC code: L04AX05
Farmakoterapeutiline rühm: immunosupressandid, teised immunosupressandid, ATC-kood: L04AX05
Pharmacotherapeutic group: immunosuppressants, selective immunosuppressants, ATC code L04AA06
Farmakoterapeutiline rühm: immunosupressandid, selektiivsed immunosupressandid, ATC-kood: L04AA06
Pharmacotherapeutic group: Immunosuppressants, Tumor Necrosis Factor alpha (TNF-α) inhibitors,ATC code: L04AB01
Farmakoterapeutiline rühm: immunosupressandid, tuumornekroosifaktori alfa (TNF-α) inhibiitorid, ATC-kood: L04AB01.
Pharmacotherapeutic group: immunosuppressants, tumour necrosis factor alpha (TNFα) inhibitors, ATC code: L04AB02.
Farmakoterapeutiline rühm: immunosupressandid, tuumornekroosifaktor alfa (TNFα) inhibiitorid, ATC-kood: L04AB02.
Pharmacotherapeutic group: immunosuppressants, tumour necrosis factor alpha (TNFα) inhibitors, ATC code: L04AB02.
Farmakoterapeutiline rühm: immunosupressandid, tuumornekroosifaktori alfa (TNFα) inhibiitorid, ATC-kood: L04AB02.
Pharmacotherapeutic group: immunosuppressants, tumour necrosis factor alpha (TNFα) inhibitors, ATC code: L04AB05
Farmakoterapeutiline rühm: immuunosupressandid, tuumorinekroosifaktor alfa (TNF-alfa) inhibiitorid, ATC kood: L04AB05
Pharmacotherapeutic group: immunosuppressive agents ATC code L04AA06
Farmakoterapeutiline rühm: immuunosupressiivsed ained, ATC–kood: L04AA06.
Pharmacotherapeutic group: immunosuppressive agents ATC code L04AA06 Mechanism of action
Farmakoterapeutiline rühm: immuunosupressiivsed ained, ATC–kood: L04AA06 Toimemehhanism
Pharmacotherapeutic group: immunosuppressive agents ATC code: LO4A A06 Mechanism of action
Farmakoterapeutiline rühm: immuunsupressiivsed ained, ATC–kood: L04AA06 Toimemehhanism
Pharmacotherapeutic group: Inactivated bacterial vaccine ATCvet code: QI 01AB07
Farmakoterapeutiline grupp: inaktiveeritud baktervaktsiin, ATC-vet kood: QI 01AB07
Pharmacotherapeutic group: inactivated bacterial vaccine.
Farmakoterapeutiline rühm: inaktiveeritud bakteriaalne vaktsiin.
Pharmacotherapeutic group: Inactivated bacterial vaccines for pigs, erysipelothrix.
Farmakoterapeutiline rühm: Inaktiveeritud baktervaktsiinid sigadele, Erysipelothrix.
Pharmacotherapeutic group: Inactivated porcine circovirus vaccine.
Farmakoterapeutiline rühm: inaktiveeritud vaktsiin sigade tsirkoviiruse vastu.
Pharmacotherapeutic group: Inactivated viral and bacterial vaccines for pigs.
Farmakoterapeutiline rühm: inaktiveeritud viirus- ja baktervaktsiinid sigadele.
Pharmacotherapeutic group: Inactivated viral and inactivated bacterial vaccines for pigs.
Farmakoterapeutiline rühm: inaktiveeritud viirus- ja baktervaktsiinid sigadele.
Pharmacotherapeutic group: Inactivated viral vaccines for sheep, bluetongue virus.
Farmakoterapeutiline rühm: Inaktiveeritud viirusvaktsiin lammastele, bluetongue viirus.
Pharmacotherapeutic group: Inactivated viral vaccines – bluetongue virus vaccine.
Farmakoterapeutiline rühm: inaktiveeritud viirusvaktsiin – bluetongue viirusvaktsiin.
Pharmacotherapeutic group: Inactivated viral vaccines – Bluetongue virus.
Farmakoterapeutiline rühm: Inaktiveeritud viirusvaktsiin – Bluetongue viirus.
Pharmacotherapeutic group: Inactivated viral vaccines – Bluetongue virus.
Farmakoterapeutiline rühm: Inaktiveeritud viirusvaktsiin–Bluetongue viirus.
Pharmacotherapeutic group: Influenza vaccine ATC Code J07BB02.
Farmakoterapeutiline grupp: gripivaktsiin, ATC-kood: J07BB02.
Pharmacotherapeutic group: Influenza vaccines, ATC Code J07BB01 Clinical studies with Celvapan (H1N1)v currently provide:
Farmakoterapeutiline grupp: gripivaktsiinid, ATC kood J07BB01 Celvapani (H1N1)v kliinilised uuringud on andnud järgmisi tulemusi.
Pharmacotherapeutic group: Influenza vaccines, ATC Code J07BB01 This section describes the clinical experience with the H5N1 vaccine.
Farmakoterapeutiline rühm: gripivaktsiinid, ATC kood: J07BB01 Käesolev lõik kirjeldab kliinilisi kogemusi H5N1 vaktsiiniga.
Pharmacotherapeutic group: Influenza vaccines, ATC Code J07BB02 Immune response againstA/Vietnam/1194/2004 :
Farmakoterapeutiline grupp: Gripivaktsiin, ATC kood J07BB02 A/Vietnam/1194/2004 (H5N1) suhtes tekkiv immuunvastus: